AzTrials
AzTrials

Cerebral Palsy Spastic DiplegiaNCT07072533

Effect of Blood Flow Restriction With Aerobic Training on Chest Muscles in Diaplegic Cerebral Palsy

A study testing blood flow restriction training in people with Cerebral Palsy Spastic Diplegia, run by Cairo University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

To evaluate the effect of blood flow restriction combined with aerobic training on chest muscle strength in individual with diaplegic cerebral palsy Read more about this study

Who is it for?
Ages 12 to 25 years
Conditions the study is for
Cerebral Palsy Spastic Diplegia
What is being tested?
blood flow restriction training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
No sites listed yet
Study dates
Aug 2025to Feb 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 25 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • diaplegic cerebral palsy. GMFCS level I-III. medically stable.

Who cannot join

  • severe cognitive impairment. cardio respiratory contraindication. previous thoracic surgery or musculoskeletal deformities affecting chest.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Salah Eid Ahmed Ali, Assis Lect contact

01158125773

Salah.Eid@sue.edu.eeg

About this study

To evaluate the effect of blood flow restriction combined with aerobic training on chest muscle strength in individual with diaplegic cerebral palsy

Read the detailed description

combining blood flow restriction with aerobic training may enhance muscle function and endurance by increasing localized metabolic stress and systemic cardiovascular effects inducing muscular hypertrophy and strength gaining with low load training especially chest muscles which affected in individuals with diaplegic cerebral palsy.

Being tested
blood flow restriction training
Medical subject headings
Cerebral Palsy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • blood flow restriction trainingOther

    Also called aerobic training

    individual will do aerobic training .

Study groups in NCT07072533
Study groupRoleWhat they receive
blood flow restriction combined with aerobic trainingExperimentalindividual will do blood flow restriction aerobic training
Receives: Other: blood flow restriction training
aerobic training onlyActive comparatorindividual will do aerobic training
Receives: Other: blood flow restriction training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Chest muscle strength

    chest muscle strength will be measured by handheld dynamometry measured in Newton

    Measured: 3 months

Secondary outcomes (4)
  1. pulmonary function tests

    pulmonary function tests in the form of forced vital capacity and forced expiratory volume in one second will be measured in Liters

    Measured: 3 months

  2. sub-maximal aerobic capacity

    sub-maximal aerobic capacity will be measured using six minute walk test measured in seconds

    Measured: 3 months

  3. quality f life

    quality f life will be measured using the pediatric quality of life inventory measured in scores from zero point to four points

    Measured: 3 months

  4. oxygen saturation and heart rate response

    oxygen saturation and heart rate response will be measured using pulse oximeter measured in percentage for oxygen saturation and pulses per minute for heart rate

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jul 2025
  2. Study startAug 2025 (estimated)
  3. Primary completionDec 2025 (estimated)
  4. Study completionFeb 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Group A which is the experimental group treated with blood flow restriction plus aerobic training and group B which is the control group treated with aerobic trainin only.
Masking
Single blind
Who is masked
Participant
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07072533
Sponsor's protocol ID
SREC.PT.SUE(11)625
Status last verified
Jul 2025
First submitted
28 Jun 2025
Last updated
18 Jul 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing blood flow restriction training in people with Cerebral Palsy Spastic Diplegia, run by Cairo University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 18 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Salah Eid Ahmed Ali, Assis Lect (01158125773, Salah.Eid@sue.edu.eeg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Chest muscle strength (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in